These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29856219)
81. Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides. Roy J; Watson JE; Hong IS; Fan TM; Das A J Med Chem; 2018 Jul; 61(13):5569-5579. PubMed ID: 29856219 [TBL] [Abstract][Full Text] [Related]
82. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. Carnevale LN; Das A Adv Exp Med Biol; 2019; 1161():219-232. PubMed ID: 31562632 [TBL] [Abstract][Full Text] [Related]
83. Biocatalytic regio- and stereoselective access to ω-3 endocannabinoid epoxides with peroxygenase from oat flour. Sanfilippo C; Patti A Bioorg Chem; 2021 Aug; 113():105014. PubMed ID: 34077840 [TBL] [Abstract][Full Text] [Related]
84. LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide. Rand AA; Helmer PO; Inceoglu B; Hammock BD; Morisseau C Methods Mol Biol; 2018; 1730():123-133. PubMed ID: 29363071 [TBL] [Abstract][Full Text] [Related]
85. Targeting the endocannabinoid system as a potential anticancer approach. Schwarz R; Ramer R; Hinz B Drug Metab Rev; 2018 Feb; 50(1):26-53. PubMed ID: 29390896 [TBL] [Abstract][Full Text] [Related]
86. Anti-inflammatory ω-3 endocannabinoid epoxides. McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674 [TBL] [Abstract][Full Text] [Related]
87. Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy. Zhang Q; Zhu B; Li Y Front Immunol; 2017; 8():71. PubMed ID: 28210259 [TBL] [Abstract][Full Text] [Related]
88. Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents. Ladin DA; Soliman E; Griffin L; Van Dross R Front Pharmacol; 2016; 7():361. PubMed ID: 27774065 [TBL] [Abstract][Full Text] [Related]
89. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells. Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716 [TBL] [Abstract][Full Text] [Related]
90. Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy. D'Eliseo D; Velotti F J Clin Med; 2016 Jan; 5(2):. PubMed ID: 26821053 [TBL] [Abstract][Full Text] [Related]
91. Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2. Niu F; Zhao S; Xu CY; Sha H; Bi GB; Chen L; Ye L; Gong P; Nie TH Oncol Lett; 2015 Oct; 10(4):2415-2421. PubMed ID: 26622862 [TBL] [Abstract][Full Text] [Related]
92. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Kroeze WK; Sassano MF; Huang XP; Lansu K; McCorvy JD; Giguère PM; Sciaky N; Roth BL Nat Struct Mol Biol; 2015 May; 22(5):362-9. PubMed ID: 25895059 [TBL] [Abstract][Full Text] [Related]
93. Cannabinoids as therapeutic agents in cancer: current status and future implications. Chakravarti B; Ravi J; Ganju RK Oncotarget; 2014 Aug; 5(15):5852-72. PubMed ID: 25115386 [TBL] [Abstract][Full Text] [Related]
94. Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Zhang G; Panigrahy D; Hwang SH; Yang J; Mahakian LM; Wettersten HI; Liu JY; Wang Y; Ingham ES; Tam S; Kieran MW; Weiss RH; Ferrara KW; Hammock BD Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11127-32. PubMed ID: 25024195 [TBL] [Abstract][Full Text] [Related]
95. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Zhang G; Panigrahy D; Mahakian LM; Yang J; Liu JY; Stephen Lee KS; Wettersten HI; Ulu A; Hu X; Tam S; Hwang SH; Ingham ES; Kieran MW; Weiss RH; Ferrara KW; Hammock BD Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6530-5. PubMed ID: 23553837 [TBL] [Abstract][Full Text] [Related]